147 related articles for article (PubMed ID: 26111043)
1. Efficacy and Tolerability of Mometasone Furoate in Lichen Sclerosus: Further Confirming Evidence.
Virgili A; Minghetti S; Corazza M; Borghi A
J Low Genit Tract Dis; 2015 Jul; 19(3):e58. PubMed ID: 26111043
[No Abstract] [Full Text] [Related]
2. Vulvar lichen sclerosus: a comparison of the short-term topical application of clobetasol dipropionate 0.05% versus mometasone furoate 0.1%.
Murina F; Rehman S; Di Francesco S; Mantegazza V; Felice R; Bianco V
J Low Genit Tract Dis; 2015 Apr; 19(2):149-51. PubMed ID: 25023331
[TBL] [Abstract][Full Text] [Related]
3. Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment?
Corazza M; Virgili A; Toni G; Borghi A
J Dermatolog Treat; 2018 May; 29(3):305-309. PubMed ID: 28753097
[TBL] [Abstract][Full Text] [Related]
4. Topical interventions for genital lichen sclerosus.
Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424
[TBL] [Abstract][Full Text] [Related]
5. Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: results from a comparative trial.
Corazza M; Borghi A; Minghetti S; Toni G; Virgili A
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):956-61. PubMed ID: 25904498
[TBL] [Abstract][Full Text] [Related]
6. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
[TBL] [Abstract][Full Text] [Related]
7. Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment.
Borghi A; Corazza M; Minghetti S; Toni G; Virgili A
J Dermatol; 2016 Sep; 43(9):1078-82. PubMed ID: 27075682
[TBL] [Abstract][Full Text] [Related]
8. Growing evidence for topical mometasone fuoroate in the treatment of Vulvar Lichen Sclerosus.
Virgili A; Corazza M; Minghetti S; Borghi A
Maturitas; 2015 Jan; 80(1):113-5. PubMed ID: 25449823
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate?
Borghi A; Minghetti S; Toni G; Virgili A; Corazza M
J Dermatolog Treat; 2017 Sep; 28(6):559-563. PubMed ID: 28024127
[TBL] [Abstract][Full Text] [Related]
10. Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment.
Corazza M; Maietti E; Toni G; Virgili A; Borghi A
Dermatol Ther; 2018 Nov; 31(6):e12735. PubMed ID: 30334327
[TBL] [Abstract][Full Text] [Related]
11. Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: results of a randomized trial.
Borghi A; Corazza M; Minghetti S; Toni G; Virgili A
Br J Dermatol; 2015 Dec; 173(6):1381-6. PubMed ID: 26280156
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological analysis of 345 cases of vulvar lichen sclerosus and a preliminary study on the frequency of maintenance treatment].
Sun XY; Xiao YP; Sun YX; Zhang Q; Cong Q
Zhonghua Fu Chan Ke Za Zhi; 2024 Jan; 59(1):56-63. PubMed ID: 38228516
[No Abstract] [Full Text] [Related]
13. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability.
Virgili A; Borghi A; Toni G; Minghetti S; Corazza M
Br J Dermatol; 2014 Aug; 171(2):388-96. PubMed ID: 24641522
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
Funaro D; Lovett A; Leroux N; Powell J
J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
[TBL] [Abstract][Full Text] [Related]
16. Lichen sclerosus involving the vagina.
Longinotti M; Schieffer YM; Kaufman RH
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1217-9. PubMed ID: 16260578
[TBL] [Abstract][Full Text] [Related]
17. Novel Therapeutic Approaches and Targets for Treatment of Vulvar Lichen Sclerosus.
Borghi A; Corazza M
Curr Pharm Biotechnol; 2021; 22(1):99-114. PubMed ID: 32416670
[TBL] [Abstract][Full Text] [Related]
18. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.
Spada F; Barnes TM; Greive KA
Australas J Dermatol; 2018 Aug; 59(3):e168-e174. PubMed ID: 29411351
[TBL] [Abstract][Full Text] [Related]
19. Topical testosterone versus clobetasol for vulvar lichen sclerosus.
Ayhan A; Guven S; Guvendag Guven ES; Sakinci M; Gultekin M; Kucukali T
Int J Gynaecol Obstet; 2007 Feb; 96(2):117-21. PubMed ID: 17239881
[TBL] [Abstract][Full Text] [Related]
20. Reduced Risk of Squamous Cell Carcinoma With Adequate Treatment of Vulvar Lichen Sclerosus.
Cooper SM; Madnani N; Margesson L
JAMA Dermatol; 2015 Oct; 151(10):1059-60. PubMed ID: 26069940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
